Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1994-07-13
1999-11-09
Hill, Jr., Robert J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 8, 514 12, 514 49, 514 50, 530396, 424 857, A61K 3800, A61K 3816
Patent
active
059814934
ABSTRACT:
A method of treating an individual who is suffering from human immunodeficiency virus infection is disclosed. The method comprises administering to a human who is suffering from human immunodeficiency virus infection, an amount of ricin, abrin, modeccin, viscumin or volkensin effective to eliminate mononuclear phagocyte lineage cells.
REFERENCES:
patent: 4795739 (1989-01-01), Lifson et al.
patent: 4869903 (1989-09-01), Lifson et al.
patent: 5141923 (1992-08-01), Byers et al.
Barbieri et al., "Volkensin, the Toxin of Adenia Volkensii (Kilyambiti Plant)", FEBS Letters 171(2):277-279 (1984).
Fernandez-Puentes et al., "Viral Infection Permeablizes Mammalian Cells to Protein Toxins", Cell 20:769-775 (1980).
Fodstad et al., "Phase I Study of the Plant Protein Ricin", Cancer Res. 44:862-865 (1984).
McGrath, et al., "GLQ223: An Inhibitor of Human Immunodeficiency Virus Replication in Acutely and Chronically Infected Cells of Lymphocyte and Mononuclear Phagocyte Lineage", Proc. Natl. Acad. Sci. USA 86:28445-28448 (1989).
Metzler et al., "Macrophages and the Human Immunodeficiency Virus", Immunology Today 11(6):217-223 (1990).
Olsenes et al., "Isolation and Properties of Abrin: A Toxic Protein Inhibiting Protein Synthesis", Eur. J. Biochem. 35:179-185 (1973).
Olsenes et al., "Purification and Characterization of the Highly Toxic Lectin Modeccin", J. Biol. Chem. 253(14):5069-5073 (1978).
Pauza, C.D., "HIV Persistence in Monocytes Leads to Pathogenesis and AIDS", Cellular Immunol. 112:414-424 (1988).
Simmons et al., "A Single Affinity Column Step Method for the Purification of Ricin Toxin from Castor Beans (Ricinus communis)", Analytical Biochemistry 146:206-210 (1985).
Simmons et al., "Mannose Receptor-Mediated Uptake of Ricin Toxin and Ricin A Chain by Macrophages", J. Biol. Chem. 261(17):7912-7920 (1986).
Till et al., "Human Immunodeficiency Virus-Infected T Cells and Monocytes are Killed by Monoclonal Human Anti-gp41 Antibodies Couples to Ricin A Chain", Proc. Natl. Sci. USA 86:1987-1991 (1989).
Yarchoan et al., "Anti-Retroviral Therapy of Human Immunodeficiency Virus Infection: Current Strategies of Challenges for the Future", Blood 78(4):859-884 (1991).
Zenilman et al., "Use of Ricin A-Chain to Selectively Deplete Kupffer Cells", Journal of Surgical Research 45:82-89 (1988).
Zenilman et al., "Selective Depletion of Kupffer Cells in Mice by Intact Ricin", Transplantation 41(1):200-203 (1989).
Ziska et al., "The Lectin from Viscum Album L. Purification by Biospecific Affinity Chromatography", Experientia 34:123-124 (1978).
Sandstrom et al, Review Articles in Drugs, vol. 34, No. 3, pp. 373-390, Sep. 1987.
Haynes, Science, vol. 260, pp. 1279-1286, May 28, 1993.
Fox, Bio/Technology, vol. 12, p. 128, Feb. 12, 1994.
Brown, The Washington Post, Jun. 10, 1993.
Greene, Scientific America, pp. 99-105, Sep. 1993 issue.
Fodstad et al, Cancer Res. vol. 44, pp. 862-865, 1984.
Yarchoan et al, Blood, vol. 78, No. 4, pp. 859-884, 1991.
Fernandez-Puentes et al, Cell, vol. 20, pp. 277-279, 1980.
Chaundhary et al, Nature, vol. 335, pp. 369-372, Sep. 22, 1988.
Hill Jr. Robert J.
Mohamed Abdel A.
LandOfFree
Method of treating humans infected with human immunodeficiency v does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating humans infected with human immunodeficiency v, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating humans infected with human immunodeficiency v will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456023